Congress Asset Management’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$3.44M	Buy	72,851 +121	+0.2%	+$5.71K	0.02%	250
2025 Q1	$2.84M	Sell	72,730 -263	-0.4%	-$10.3K	0.02%	255
2024 Q4	$3.95M	Buy	72,993 +6,352	+10%	+$344K	0.03%	248
2024 Q3	$3.36M	Buy	+66,641	New	+$3.36M	0.02%	252